glp 1 based therapy for diabetes Expanding applications of therapies on GLP1 How to use GLP-1 receptor

Human data from diabetics suggest longer lifespans compared to non-diabetics, but its unclear if this applies to healthy people

All randomized participants received at least one dose of the study drug and were included in both the full and safety analysis populations [1]

Papillary thyroid cancer was the most common thyroid cancer subtype, followed by follicular, medullary, and other types

Atwell and coworkers evaluated the effect of either a supplement containing standardized concentration of glucoraphanin with myrosinase enzyme (BroccoMax) or placebo for a minimum of 2-week in women with abnormal mammograms and booked for breast biopsies